This is a double blind placebo controlled clinical study designed to determine the effects of
leptin on the changes that occur in the body during weight loss achieved by a very low
calorie diet.
Phase:
Phase 2
Details
Lead Sponsor:
Rockefeller University
Collaborators:
Columbia University St. Luke's-Roosevelt Hospital Center Weill Medical College of Cornell University